BI
BioAge Labs, Inc. (BIOA)
NASDAQ·Healthcare·Biotechnology
$17.46
-3.32%
Mkt Cap $613.46M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$42.50
Range $23.00 – $62.00
Implied Upside
+143.4%
Consensus $42.50 vs current $17.46
NASDAQ·Healthcare·Biotechnology
$17.46
-3.32%
Mkt Cap $613.46M
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$42.50
Range $23.00 – $62.00
+143.4%
Consensus $42.50 vs current $17.46